Connection

Andrea Calcagno to HIV-1

This is a "connection" page, showing publications Andrea Calcagno has written about HIV-1.
Connection Strength

0.458
  1. Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions? AIDS. 2019 03 15; 33(4):759-762.
    View in: PubMed
    Score: 0.262
  2. CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose. Curr HIV/AIDS Rep. 2018 02; 15(1):84-91.
    View in: PubMed
    Score: 0.061
  3. The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment. Antivir Ther. 2018; 23(5):451-456.
    View in: PubMed
    Score: 0.060
  4. Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study. J Antimicrob Chemother. 2017 10 01; 72(10):2879-2886.
    View in: PubMed
    Score: 0.059
  5. Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients. J Antimicrob Chemother. 2017 Nov 01; 72(11):3163-3166.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.